Get started
Author

James Morgan

Observed names: J MORGAN, J Morgan, J. Morgan, James A Morgan
ORCID: 0000-0001-8595-5372
Observed ORCID: 0000-0001-8595-5372
OpenAlex ID: A5088664095
Comparative effectiveness of ustekinumab or vedolizumab after one year in 130 patients with anti‐TNF‐refractory Crohn’s disease
2020 · Tristan Townsend, Violeta Razanskaite, et al. · Alimentary Pharmacology & Therapeutics · 77
Time to endoscopy for acute upper gastrointestinal bleeding: Results from a prospective multicentre trainee‐led audit
2018 · Keith Siau, James Hodson, et al. · United European Gastroenterology Journal · 43
PDF
Anorexia nervosa and the gastrointestinal tract
2021 · Wisam Jafar, James Morgan · Frontline Gastroenterology · 25
PDF
Intestinal failure-associated liver disease in adult patients
2019 · James Morgan, Martyn Dibb, et al. · Current Opinion in Clinical Nutrition & Metabolic Care · 17
P401 Pregnancy outcomes in women with inflammatory bowel disease exposed to infliximab
2013 · Y. Snoeckx, M. Clark, et al. · Journal of Crohn s and Colitis · 6
P046 Liver re-transplantation in adults; a single UK centre experience (2009–2020)
2021 · James Morgan, Sara Mahgoub, et al. · Gut · 2
PDF
P586 Comparative effectiveness of vedolizumab and ustekinumab as induction therapy in anti-TNF refractory Crohn’s disease: a multi-centre retrospective cohort study
2019 · T Townsend, V Razanskaite, et al. · Journal of Crohn s and Colitis · 2
Difference in nutrition and environmental exposures in patients with Barrett's and GERD
2001 · P BANERJEE, S ATTARCHI, et al. · Gastroenterology · 2
Managing intestinal failure in inflammatory bowel disease - ‘when the drugs don’t work’
2020 · James Morgan, Ashley Bond, et al. · Frontline Gastroenterology · 1
Outcomes of risankizumab use in adults with Crohn’s disease in a real-world setting (ARISE-CD): a multicentre, retrospective cohort study
2026 · Thomas D Butler, Anthony Beard, et al. · BMJ Open Gastroenterology
P0302 Evaluating the efficacy of risankizumab in Ulcerative Colitis: Experiences of a UK hospital
2026 · J Morgan, W Jafar, et al. · Journal of Crohn s and Colitis
Trends in eating disorder admissions to an acute NHS hospital: a retrospective review
2025 · Wisam Jafar, Bethany Miller, et al. · Frontline Gastroenterology
P152 The impact of the COVID-19 pandemic on upper GI two-week wait referrals and cancer diagnoses
2023 · Hannah Morgan, Sarah Guthrie, et al. · Gut
P151 Could H Pylori testing reduce the number of patients unnecessarily referred on the upper GI suspected cancer pathway?
2023 · Hannah Morgan, Sarah Guthrie, et al. · Gut
P047 Nutrition in decompensated liver disease: A regional trainee-led audit investigating malnutrition and the impact of nutritional interventions following admission with decompensated chronic liver disease
2021 · James Morgan, Lauren O’Flynn, et al. · Gut
PDF
P354 A multi-centre audit of lower gastrointestinal bleeding management
2021 · Michael Davies, Tristan Townsend, et al. · Gut
PDF
P162 Comparative effectiveness of vedolizumab and ustekinumab in anti-TNF refractory Crohn’s disease: Multi-centre retrospective cohort study
2021 · Tristan Townsend, Violeta Razanskaite, et al. · Gut
PDF
PTH-131 Multi-centre comparative effectiveness of vedolizumab and ustekinumab as induction therapy in anti-TNF refractory Crohn’s disease
2019 · Violeta Razanskaite, Stephanie Michail, et al. · Gut
PDF
P422 The Biologics Register for inflammatory bowel disease in the UK: Setting the clinical dataset and the IT infrastructure
2012 · L. Alrubaiy, J. Williams, et al. · Journal of Crohn s and Colitis
Works count: 19
Citation count: 175
H-index: 5
I10-index: 4
Year
Topic
Type